The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Ozempic was first approved by the FDA in 2017 for blood sugar control in Type 2 diabetes. It received a cardiovascular indication in 2020 and is now the most broadly indicated GLP-1 receptor agonist ...

The Cleveland Clinic also warns against buying into the “nature’s Ozempic” hype, but says the supplement could also aid in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Everyone should be eating protein, but Dr. Sowa says it’s "very, very important" when you’re on a weight loss journey. “It’s ...

The driver of a 4×4 that ploughed into a primary school killing two eight-year-old girls has been rearrested after bereaved ...

The HC was hearing a writ petition filed by two residents’ associations in Mumbai’s suburban Nehru Nagar, Kurla (East) and ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A systematic review of existing medicines has found that antibiotics and vaccinations are associated with a reduced risk of ...

The tech firms that host the app are putting their shareholders at risk by failing to comply with the law.